drugset / Trial / NCT00711048

Esophageal Hypersensitivity Study in Healthy Volunteers

NCT00711048

Phase 1 Completed 45 enrolled AstraZeneca
RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of the study is to compare sensitivity and sensitization of visceral pain in the esophagus using different pain stimuli

Timeline

Start
2008-06
Primary completion
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1386 Small molecule 30 mg Oral
Subject AZD1386 Small molecule 95 mg Oral

Indications

No indication recorded.